Karl Härfstrand
Founder at Härfstrand Consulting AG
Net worth: - $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Johan Luthman | M | 65 |
Karolinska Institutet
| 7 years |
| Daniel Welch | M | 66 | - | |
| Robert Maiorana | M | 64 | 4 years | |
| Oleg Nodelman | M | 47 | 5 years | |
| Hege Hellstrom | M | 59 | 5 years | |
| Brandon Smith | M | 50 | 4 years | |
| Theresa Tse | F | 32 | 7 years | |
| Michael J. Malecek | M | 58 | 5 years | |
| Paula Cobb | F | 51 | 5 years | |
| Helen Kim | F | 61 | 2 years | |
| Michael Bachner | M | - | 2 years | |
| Johanna Röstin | F | 57 | 3 years | |
| Michael MacDougall | M | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 17 years |
| Roger Tell | M | 59 | 2 years | |
| Antonio Lanzavecchia | M | 73 |
Humabs BioMed SA
 Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | 13 years |
| Carol Karp | F | 71 | 8 years | |
| Pål Ryfors | M | 41 | 2 years | |
| Hideki Garren | M | 60 | 3 years | |
| William Dunn | M | 54 | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Arend William Burema | M | 66 | 3 years | |
| Dale B. Schenk | M | 66 | 4 years | |
| Hanne Leth Hillman | F | 59 | 3 years | |
| John Weiland | M | 68 |
Pharmacia AB
| - |
| Lars Terney | M | - | 2 years | |
| Jim van Heusden | M | 53 | 2 years | |
| Ulrik Ditlev Eriksen | M | - | 10 years | |
| Andrea Buscaglia | M | 60 |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | 4 years |
| Lynn A. Taylor | F | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Gunilla Öhman | F | 65 | 1 years | |
| Jennifer Zibuda | F | - | 3 years | |
| Gunnar Magnus Modee Persson | M | 64 | 3 years | |
| Achim Schäffler | M | - |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | 6 years |
| Sanjiv Patel | M | 50 | 2 years | |
| François Martelet | M | 64 | 2 years | |
| Kim Arvid Nielsen | M | 65 | 3 years | |
| Arthur William Homan | M | 64 | 5 years | |
| Henrijette Richter | M | 53 | 3 years | |
| Robert Schmid | M | 65 | - | |
| Jan Hermansson | M | 68 |
Pharmacia & Upjohn, Inc.
Karolinska Institutet
| 7 years |
| Carl Johan Bertil Sundberg | M | 66 | 3 years | |
| Gilles V. J. Pajot | M | 74 |
Pharmacia & Upjohn, Inc.
Pharmacia AB
| 3 years |
| Göran Albert Ando | M | 75 |
Pharmacia & Upjohn, Inc.
Pharmacia AB
| 8 years |
| Christopher Henney | M | 83 | 9 years | |
| Jonas Nilsen | M | - | 4 years | |
| Fred Hassan | M | 78 |
Pharmacia & Upjohn, Inc.
| 3 years |
| Tara Nickerson | M | 51 | 6 years | |
| Richard Åhlberg | M | - |
Karolinska Institutet
| 12 years |
| Carina Eklöw | F | - | 1 years | |
| Jochen Mattis | M | - |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | 6 years |
| Ulf Rosén | M | 64 |
Pharmacia & Upjohn, Inc.
| 3 years |
| Martin D. Meglasson | M | 74 |
Pharmacia, Inc.
Pharmacia & Upjohn, Inc.
| 7 years |
| Bo Jesper Hansen | M | 66 | 4 years | |
| Fredrik Järrsten | M | 57 | 4 years | |
| Devin Smith | M | 56 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Goetz Kalckreuth | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 8 years |
| Jean-Marc Dardier | M | - | - | |
| Jessica Martinsson | F | 52 |
Pharmacia & Upjohn, Inc.
| - |
| Steven Jon Axon | M | 49 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Joakim Lindén | M | - | - | |
| Peter Selin | M | - | - | |
| Heidi Ramstad | M | 55 | - | |
| Karl Magnus Olof Johannes Edner | M | 68 |
Karolinska Institutet
| 6 years |
| Maria Nilsson Hagberg | F | - | 2 years | |
| Mark DeLong | M | 47 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 11 years |
| Christer Nordstedt | M | 62 |
Karolinska Institutet
| 5 years |
| Jan-Ingmar Flock | M | 75 |
Karolinska Institutet
| 3 years |
| Jonathan Freeman | M | 56 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 6 years |
| Desiree Luthman | M | 65 |
Karolinska Institutet
| 3 years |
| Ruud van Anraat | M | 62 | - | |
| Mats Norman | M | 61 |
Karolinska Institutet
| 4 years |
| Carrie Cox | F | 66 |
Pharmacia & Upjohn, Inc.
| - |
| Alice Heezen | F | 54 | 3 years | |
| Christian Henrik Tange | M | 58 | 3 years | |
| Ellen Chiniara | F | 65 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 4 years |
| Bob C. Salisbury | M | 80 |
Pharmacia & Upjohn, Inc.
| - |
| Ley Smith | M | 90 |
Pharmacia & Upjohn, Inc.
| 39 years |
| Craig Tooman | M | 58 |
Pharmacia & Upjohn, Inc.
| - |
| Reinhard Koenig | M | 64 | - | |
| Carl Harald Janson | M | 66 |
Karolinska Institutet
| 3 years |
| Andreas Rummelt | M | 67 | 2 years | |
| Hans-Olov Olsson | M | 83 | - | |
| Hans Ture Staffan Ek | M | 79 |
Pharmacia AB
| 20 years |
| Luzi Andreas von Bidder | M | 71 | 16 years | |
| Alf E. A. Lindberg | M | 85 |
Karolinska Institutet
| 10 years |
| Johan Rutger Christenson | M | 65 |
Karolinska Institutet
| 14 years |
| Robert Gorman | M | - |
Pharmacia & Upjohn, Inc.
| - |
| Laura González Molero | F | 59 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 7 years |
| James Sapirstein | M | 63 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Carl-Johan Spak | M | 68 |
Karolinska Institutet
| 9 years |
| Philip Lockwood | M | 75 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 4 years |
| Lars Gunnar Lannfelt | M | 75 |
Karolinska Institutet
| 3 years |
| Lars Gösta Jonsson | M | 83 |
Karolinska Institutet
| 19 years |
| Bruno C. Musch | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Thomas Bengt Eldered | M | 64 |
Pharmacia AB
| 8 years |
| Daniel Spasic | M | - |
Pharmacia & Upjohn, Inc.
| - |
| Jürgen Betzing | M | 61 | - | |
| Staffan O. Bjoeoern | M | - | - | |
| Marcel von Ah | M | 53 | 8 years | |
| Annette Eschler | M | 59 | 3 years | |
| MARIA V BRESNAHAN | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 42 | 42.00% |
| United States | 26 | 26.00% |
| Ireland | 16 | 16.00% |
| Switzerland | 13 | 13.00% |
| Denmark | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Karl Härfstrand
- Personal Network